20151192: OPKO Health, Inc.; Bio-Reference Laboratories, Inc.
Date: July 1, 2015
Acquiring Party: OPKO Health, Inc.
Acquired Party: Bio-Reference Laboratories, Inc.
Bio-Reference Laboratories, Inc.
FTC has signed off on the deal. BRLI may now proceed to schedule a shareholder vote on the deal.
MannKind Triples Production Capacity for Afrezza
VALENCIA, Calif., July 31, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today announced that it has completed the validation of two additional filling lines for the manufacture of Afrezza® (insulin human) inhalation powder. Material produced during the validation runs, including the recently approved 12 unit cartridges, will be supplied to Sanofi to support the launch of the new dosage strength, which is expected later this quarter.
"With the completion of the validation effort, which began last quarter, we can support a demand of more than 300 million cartridges per year," stated Hakan Edstrom, President and CEO of MannKind Corporation. "The addition of the 12 unit cartridge will provide patients with another option to receive their prescribed dose."
OPK will be moving upwards of 20, probably upwards of 30. And then there will be a forward stock split, probably 3 for 2.
As for the final "price" that the BRLI folks will enjoy, I can only relate an interview I viewed or read where the interviewer said that Frost sold Ivax to Teva for 7.5 billion dollars. Oh come to think of it, I viewed it, b/c Frost just smiled and said it was close to 10B dollars as the price of Teva stock went up by the time the deal closed.
I wouldn't be surprised if that interview was available via Utube. Unfortunately, I have no idea just how to search for it there. Just something I remembered.
Tesaro and Jiangsu Hengrui Medicine Announce Rolapitant License Agreement for China
WALTHAM, Mass., July 30, 2015 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, and Jiangsu Hengrui Medicine Co., Ltd., a fully integrated pharmaceutical company based in China, today announced an exclusive license agreement for the development, registration, manufacture, and commercialization of rolapitant in China. Hengrui will make upfront and milestone payments to TESARO subject to the achievement of certain events, in addition to royalty payments on annual net sales in China. Additional financial details were not disclosed.
"TESARO is committed to advancing new therapeutic options for patients with cancer, and we are pleased to be working with Hengrui to develop and commercialize rolapitant for patients in China," said Lonnie Moulder, CEO of TESARO. "Hengrui is a leading innovative pharmaceutical company in China, with a substantial portfolio of marketed oncology products, deep regulatory expertise, and a robust pipeline of product candidates. With a strong commitment to quality and a significant level of expertise in clinical development, regulatory affairs, and commercialization, we believe Hengrui is the optimal partner to develop rolapitant in China."
Piaoyang Sun, Chairman of the Board of Hengrui, added, "As one of the leading pharmaceutical companies in China, Hengrui has a rich history of delivering high quality oncology products worldwide and continues to be committed to developing innovative oncology medicines. In recent years, Hengrui has expanded its oncology portfolio to include cancer supportive care products, and the development and commercialization of rolapitant for China is the most recent example of our effort to make new therapeutic options available to millions of cancer patients here. We are extremely pleased to be working with TESARO, an emerging leader in the development of oncology specialty medicines
I know what I know about what I own. Occasionally, some people find stuff of import and post it here. And then I know more about what I know. Seems like most of the posts here are about posters who I have chosen to ignore. I don't want to know what they said, what they are thinking, or if they are alive or dead.
So, go ahead and engage them or call them out when they are absent (or have deleted their posts). That means nothing to me except for the garbage that those posts represent. Time to grow up. If you can't manage that, I am going to consign anybody who talks to or talks about trolls to the ignore bin. And that's my final answer. It probably won't change a thing other than the stuff I have to read. Yes, it's a public message board, and one can do what one wants to do. My VIEW of this message board, OTOH is my view. And I choose not to be bothered with fools.
And he indicated that OPK might not wait for the closing of the deal to get BRLI sales people calling on docs (which IMO means BRLI will be selling 4kscore before the closing).
Then I'd suggest you google Jiangsu Hengrui Medicine and discover that they are global and market products here and in the EU. They have an R&D facility in New Jersey. I had the same knee-jerk reaction, but after a little reading, and remembering that this isn't Lonnie Moulder's first rodeo, I fine with it. Oh, not only that, but Frost is fine with it, too. OPK has to approve these sub-license agreements. It's in the Exhibit 10.27 to the 10-K filed 3/16/11.
Okay, TA nonsense, as you call it, is using known data to suggest (not predict!) future data. And that should be simple enough for one to accept. If a man is staggering down the way for 3 blocks, he will probably stagger for a fourth (or fall down, or get mugged, or get busted). But to suggest that biotechs do not follow TA is either a product of listening to amateur TA "experts" and their predictions that have gone way wrong, or your own lack of study.
News can disrupt everything, and not always in a predictable way. But when the dust settles, there will still be price prints, volume prints, and maybe some clue provided by some indicator or other that people better versed in math than you or I have developed. TA is based on price and volume and time, and it comes from a record of same. There is nothing to dispute about the record. It is what it is.
That said, yes it is a good idea to beware of ANY kind of nonsense offered on these message boards. There are too many TA "experts" who have done too little study, which fails to prevent them from espousing what they "might" believe to be the case. As always, the best thing to do is to do your own "heavy lifting." Unfortunately, that might mean doing homework. Read to succeed. A mind is like a mouse trap. It works best open.
Burnaka, you wrote:
"Once this deal closes, which is still about 60 days away, shorts will not be toast, or road kill. They will be BURNT, trashed, gutter toast, putrid road kill, that gets absorbed into the tar pit we drive on.
Once this deal closes, those 35% and 16% short group will find their losses double in under 6 months. THEY are as desperate as ever, and slamming these stocks hoping for capitulation to get out from under."
This certainly applies to the retail shorts who, thinking they are much like the Club Members, follow like the sheep they claim we are. Where the rest of them are concerned, maybe they get scorched, or maybe they have a master plan made of layers of complexity only a few could see.
To which I say whatever. Been here before, and I'll be here as long as Dr. Frost is here. As for this time and tumult, "It is a tale told by an idiot, full of sound and fury, signifying nothing."
To put it another way, my fortune does not depend upon the actions of the short group, whether that be retail dummies or financial wizards. My fortune rests squarely upon my shoulders and those of Dr. Frost.
Would I rather see OPK rising into the 20's? Well of course. But as I said, been there and done that before. After all of this "carnage," I'm still up a preposterous percentage. And that will sooner or later look like chicken feed when this deal gets done and the synergy starts rolling. Some would say I am a member of the "Frost Cult." Call it what you will, makes no difference to me. What I see is Frost doing what he did with Ivax, going global. He learned a few things with that venture (which I will call a moderate success in view of what I think he has planned for Opko). So, yeah, everybody have a good time bashing and shorting and arbing. And then get out of town before the Frost Express runs your small thinking azes over. That's my story, and I'm sticking to it.
SEC made the S-4 effective late Friday. The proxy has been filed in its final form. The vote is 8/20/15. When OPK acquired PBTH, the vote was on a Thursday, and the merger completed the next day. 8/20/15 is a Thursday.
In the span of 3 days, this nimrod has:
1) suggested that maybe the FDA will not approve 4Kscore,
2) suggested that many drugs fail phase 3, so Rayaldee might fail phase 3,
3) used the mutually exclusive terms "respected" and "bank" in the same sentence.
If one is into slapstick comedy, then it might be better to just read his clownish posts for the entertainment value. But I wouldn't actually have a conversation with him.
K9uwa, your scenario is fine with one little exception. When the deal is done, BRLI will be Opko Diagnostics. Or, well, I suppose it could be called Opko Bioreference Labs. Thing is, present BRLI shareholders will (if they are smart) be owners of Opko Diagnostics (or OBL) AND all of the multitude of other Opko divisions, investments, and future assets (gee, I hope Yahoo doesn't censor that).
There was some retail pushback on the Prolor acquisition when OPK was trading around 7 bucks. Those who held their shares saw OPK go into the 19's, and they see history repeating itself. Those who sold are possibly among the bashers of OPK, BRLI and this deal. It's called sour grapes. lol
We cordially invite you to attend a special meeting of shareholders of Bio-Reference Laboratories, Inc., a New Jersey corporation, which we refer to as Bio-Reference, to be held on August 20, 2015, 9:00 a.m., local time, at the Sheraton Crossroads Hotel, Crossroads Corporate Center, One International Boulevard, Route 17 North, Mahwah, New Jersey 07495-0001. As previously announced, Bio-Reference and OPKO Health, Inc., a Delaware corporation, which we refer to as OPKO, have entered into an Agreement and Plan of Merger, dated as of June 3, 2015, which we refer to as the merger agreement. Pursuant to the terms of the merger agreement, a subsidiary of OPKO will merge with and into Bio-Reference, with Bio-Reference surviving the merger as a wholly owned subsidiary of OPKO.
Very interesting........but shtupid. Who is Colombine (other than the scene of some drug addled teens shooting up the place)? Bucket shops can employ ANALysts,too. And those that parrot what fringe players say without consideration of who and why are either in sway of those entities, or they are people who will be lunch for the bunch.
In the span of 7 days, what has fundamentally changed with OPK? What prospective sources of income have fallen out? What history do we know about Colombine?
Several of the bashers here (whether it be several, or two, or just one) have been "downgrading" OPK since it was trading at 4.50. I think that speaks for itself.
All of those buys were for his wife and a family trust for...his family.
He increased his wife's share by 52.67%. He's a good husband.
He increased the family trust's share by 126.78%.
With his personal holdings at 135,749, and the additions to the wife's share and the family trust, he now controls 168,449 shares. Well.........that's a little more than the short sales. Oh, and a little more than my long shares. I dunno, but probably more than my shares and Drangle's shares combined. So, let's hear it for Dr. Lerner. He and Doc Frost will "Lerner" a thing or two to the shorties and these johnny-come-lately FUD F'ers.
As an example of what could transpire, CEO announced on 5/4/15 it's intention to acquire PMFG. On 6/12/15, they jointly announced the early termination of the Hart Scott Rodino waiting period and that the FTC cleared the way for the deal. On 6/9/15, they filed an S-4 with the SEC which is pending. When the SEC makes that S-4 "effective," they will file a Def-14A proxy and announce a date on which the affected PMFG shareholders can vote on the merger. The deal could certainly be finalized before the end of July or a little over 2 months.
No reason why, IMO, OPK/BRLI could not do it just as fast or faster. FWIW
Some seriously disgusted serious investors cried for a place where robo-posters and trolls didn't junk up the place. And I invited several to a place where they could have a clean environment free of robo-posters and trolls.
And, as these things go, many joined. And there were some serious discussions when events merited them. And there were NO robo-posters and NO trolls. But time marches on, and nobody ever went broke underestimating the attention span of the public (H.L. Mencken,1880-1956). Actually, he said "intelligence" not attention span. So now there are maybe 4 of those pilgrims who are still posting there.
I find that funny. Not odd, for it is totally forseeable. Long ago, in a far different occupation, I was introduced to a fundamental flaw affecting most humans: We find something that works, and we quit doing it. The corollary being, we find something that doesn't work, and we keep doing it. The humble, yet familiar example was closing a cabinet door. If it works, we're done. If it doesn't work the way we did it, we do it HARDER. And if that doesn't work, we do it harder STILL, and so on until we are red-faced and ready to kick the dog, kill the cat, choke the kids........well, of course I exaggerate. But given an IQ of double digits and a modicum of humility, one does get the picture
And so, we have supposedly adult, supposedly serious people here who would rather feed the trolls than ignore them. And, beyond our control, we have robo-posters here who, for whatever reason, junk up this board.
I can tell you what we don't have: the same number of refugees that fled these corrupted fields to the safe haven of the place they once enjoyed. And that was totally predictable. Don't know about anybody else, but you don't call me predictable without raising my hackles. NTL, there you have it. FWIW
Fella, you do your homework. In the latest article, Alpert is still using the market cap from 2012.
I have you on ignore, but I just had to take a peek to see if you finally found a brain cell.
Guess not. Back you go, and, for my part, I've learned what I have already known..........you can't fix stupid.